Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin discontinuation in chronic HeartMate 3 LVAD recipients
MOH_2026-01-07_015589Phase 4Not yet recruiting
- Sponsor
- Columbia University
- Start
- Dec 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aspirin and warfarin in heart failure (HF) (2 arms), sponsored by Columbia University. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
aspirinwarfarin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on MOH_2026-01-07_015589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2026-01-07_015589.